The newly launched Bespoke Gene Therapy Consortium (BGTC), part of the NIH Accelerating Medicines Partnership (AMP) program, aims to optimize and streamline the gene therapy development process to help fill the unmet medical needs of people with rare diseases.
from NIMH News Feed https://ift.tt/3bo5bVF
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment